449 related articles for article (PubMed ID: 22017438)
21. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.
De Trez C; Schneider K; Potter K; Droin N; Fulton J; Norris PS; Ha SW; Fu YX; Murphy T; Murphy KM; Pfeffer K; Benedict CA; Ware CF
J Immunol; 2008 Jan; 180(1):238-48. PubMed ID: 18097025
[TBL] [Abstract][Full Text] [Related]
23. The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy.
Pasero C; Speiser DE; Derré L; Olive D
Curr Opin Pharmacol; 2012 Aug; 12(4):478-85. PubMed ID: 22445654
[TBL] [Abstract][Full Text] [Related]
24. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
Liu W; Chou TF; Garrett-Thomson SC; Seo GY; Fedorov E; Ramagopal UA; Bonanno JB; Wang Q; Kim K; Garforth SJ; Kakugawa K; Cheroutre H; Kronenberg M; Almo SC
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34709351
[TBL] [Abstract][Full Text] [Related]
25. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.
Rodriguez-Barbosa JI; Schneider P; Weigert A; Lee KM; Kim TJ; Perez-Simon JA; Del Rio ML
Cell Mol Immunol; 2019 Jul; 16(7):679-682. PubMed ID: 31160757
[No Abstract] [Full Text] [Related]
26. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
Murphy TL; Murphy KM
Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
[TBL] [Abstract][Full Text] [Related]
27. Immunoregulation by tumor necrosis factor superfamily member LIGHT.
Wang Y; Zhu M; Miller M; Fu YX
Immunol Rev; 2009 May; 229(1):232-43. PubMed ID: 19426225
[TBL] [Abstract][Full Text] [Related]
28. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
[TBL] [Abstract][Full Text] [Related]
29. Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.
Park SJ; Riccio RE; Kopp SJ; Ifergan I; Miller SD; Longnecker R
mBio; 2020 May; 11(3):. PubMed ID: 32398314
[TBL] [Abstract][Full Text] [Related]
30. BTLA inhibition has a dominant role in the
Battin C; Leitner J; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Olive D; Steinberger P
Front Immunol; 2022; 13():956694. PubMed ID: 36081508
[TBL] [Abstract][Full Text] [Related]
31. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
[TBL] [Abstract][Full Text] [Related]
32. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production.
Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D
Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890
[TBL] [Abstract][Full Text] [Related]
33. Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.
Bechill J; Muller WJ
Mol Immunol; 2014 Nov; 62(1):96-103. PubMed ID: 24980868
[TBL] [Abstract][Full Text] [Related]
34. Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.
Cheung TC; Coppieters K; Sanjo H; Oborne LM; Norris PS; Coddington A; Granger SW; Elewaut D; Ware CF
J Immunol; 2010 Aug; 185(3):1949-58. PubMed ID: 20592286
[TBL] [Abstract][Full Text] [Related]
35. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation.
Giles DA; Zahner S; Krause P; Van Der Gracht E; Riffelmacher T; Morris V; Tumanov A; Kronenberg M
Front Immunol; 2018; 9():2585. PubMed ID: 30524422
[TBL] [Abstract][Full Text] [Related]
36. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria.
Shui JW; Larange A; Kim G; Vela JL; Zahner S; Cheroutre H; Kronenberg M
Nature; 2012 Aug; 488(7410):222-5. PubMed ID: 22801499
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
Zhang M; Howard K; Winters A; Steavenson S; Anderson S; Smelt S; Doellgast G; Sheelo C; Stevens J; Kim H; Hamburger A; Sein A; Caughey DJ; Lee F; Hsu H; Siu G; Byrne FR
Clin Exp Immunol; 2011 Jan; 163(1):77-87. PubMed ID: 21078085
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus-based regimen promotes inhibitory costimulatory signal of HVEM/BTLA/CD160/LIGHT pathway in allo-renal recipients.
Bai Y; Shi Y; Li Y; Cai B; Zou Y; Wang L
Transpl Immunol; 2013 Jan; 28(1):38-47. PubMed ID: 23165214
[TBL] [Abstract][Full Text] [Related]
39. LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major.
Xu G; Liu D; Okwor I; Wang Y; Korner H; Kung SK; Fu YX; Uzonna JE
J Immunol; 2007 Nov; 179(10):6901-9. PubMed ID: 17982081
[TBL] [Abstract][Full Text] [Related]
40. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
